FIGURES LOOK GOOD ON LAST MONTHLYEXPANSION PROGRESS WELL UNDERWAY.CAN ONLY IMPROVE.BEING HURT BY TAX SELLERS. WILL SEE IT BACK INTO THE 20-30CENT RANGE IN NEXT FEW MONTHS
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market